But her lawyers claimed in a subsequent court filing that she also suffered from lung cancer. "I noticed that was written on one of the papers they sent me ...
And among patients with non-small-cell lung cancer, about 24% received Avastin, even though their disease didn't meet the right criteria to get the drug, ...
Positive data was reported in connection with the interim analysis in Phase II/III and from clinical Phase I trials in lung cancer, renal cell cancer and ...
According to the American Cancer Society (ACS), breast cancer is the second leading cause of cancer death in women, after lung cancer and 1 out of 8 ...
... was recording full-time shifts in Cresskill, NJ Another police officer who was listed by her lawyers as having lung cancer, doesn't have cancer at all. ...
9, 2009.) The company also is developing Opaxio (paclitaxel poliglumex), which is in Phase III in patients with previously untreated non-small-cell lung cancer.
A phase III study in advanced squamous non-small cell lung cancer on top of gemcitabine/carboplatin is being implemented. Phase II trials in ovarian cancer ...
Synta is currently conducting Phase 2 trials in non-small cell lung cancer (NSCLC) and gastrointestinal stromal tumors (GIST), two Phase 1/2 clinical trials ...
Email this story